ClinVar Miner

Submissions for variant NM_000527.5(LDLR):c.907C>T (p.Arg303Trp) (rs151207122)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 9
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
LDLR-LOVD, British Heart Foundation RCV000238462 SCV000295044 likely pathogenic Familial hypercholesterolemia 1 2016-03-25 criteria provided, single submitter literature only
GeneDx RCV000657894 SCV000779658 uncertain significance not provided 2018-05-16 criteria provided, single submitter clinical testing A variant of uncertain significance has been identified in the LDLR gene. The R303W variant (reported as R282W due to the use of alternate nomenclature) has been reported in one patient with moderate hypercholesterolemia (Arca et al., 1998). The R303W variant is observed in 9/24012 (0.04%) alleles from individuals of African ancestry in large population cohorts (Lek et al., 2016). Nonetheless, the R303W variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. Finally, in-silico analyses, including protein predictors and evolutionary conservation, support a deleterious effect. Therefore, based on the currently available information, it is unclear whether this variant is pathogenic or rare benign.
Invitae RCV000791388 SCV000825564 uncertain significance Familial hypercholesterolemia 2019-11-25 criteria provided, single submitter clinical testing This sequence change replaces arginine with tryptophan at codon 303 of the LDLR protein (p.Arg303Trp). The arginine residue is moderately conserved and there is a moderate physicochemical difference between arginine and tryptophan. This variant is present in population databases (rs151207122, ExAC 0.03%). This variant has been reported in individuals affected with hypercholesterolemia (PMID: 9544746, 24507775, 28965616). This variant is also known as p.Arg282Trp in the literature. ClinVar contains an entry for this variant (Variation ID: 161281). Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000781501 SCV000919581 uncertain significance not specified 2018-05-23 criteria provided, single submitter clinical testing Variant summary: LDLR c.907C>T (p.Arg303Trp) results in a non-conservative amino acid change located in the Low-density lipoprotein (LDL) receptor class A repeat of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4e-05 in 277062 control chromosomes (gnomAD). This frequency is not higher than expected for a pathogenic variant in LDLR causing Familial Hypercholesterolemia (4e-05 vs 1.30e-03), allowing no conclusion about variant significance. The variant, c.907C>T, has been reported in the literature in individuals affected with Familial Hypercholesterolemia (Arca_1997, Pirillo_2017), although without strong evidence for pathogenicity such as cosegregation with disease in families, thus these reports do not provide unequivocal conclusions about association of the variant with Familial Hypercholesterolemia. The Arg303 codon and adjacent codons have been implicated in Familial Hypercholesterolemia (e.g., p.303Q p.C302R, p.C302W, p.D304N, p.D304E), suggesting the codon and region may be a mutational hotspot and critical for protein function. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Three submissions to ClinVar show differing interpretations: one VUS, one likely pathogenic, and one pathogenic. Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic.
Color Health, Inc RCV000791388 SCV001346462 uncertain significance Familial hypercholesterolemia 2020-03-09 criteria provided, single submitter clinical testing
Brunham Lab, Centre for Heart and Lung Innovation,University of British Columbia RCV000238462 SCV001432670 uncertain significance Familial hypercholesterolemia 1 2019-05-10 criteria provided, single submitter research
Mayo Clinic Laboratories, Mayo Clinic RCV000657894 SCV001715243 uncertain significance not provided 2021-02-11 criteria provided, single submitter clinical testing
CSER _CC_NCGL, University of Washington RCV000148588 SCV000190302 uncertain significance Hypercholesterolaemia 2014-06-01 no assertion criteria provided research
Laboratorium voor Moleculaire Diagnostiek Experimentele Vasculaire Geneeskunde,Academisch Medisch Centrum RCV000238462 SCV000606263 pathogenic Familial hypercholesterolemia 1 no assertion criteria provided research

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.